{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:18:46Z","timestamp":1790806726225,"version":"4.1.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"am","delay-in-days":425,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1K23HL151826"],"award-info":[{"award-number":["1K23HL151826"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.tmrv.2023.150769","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T04:08:35Z","timestamp":1696392515000},"page":"150769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Leveraging Donor Populations to Study the Epidemiology and Pathogenesis of Transfusion-Transmitted and Emerging Infectious Diseases"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8181-9517","authenticated-orcid":false,"given":"Evan M.","family":"Bloch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence M.","family":"Corash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Dodd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benyam","family":"Hailu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Kleinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyle","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Stramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2023.150769_bib0001","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1182\/blood-2018-11-833996","article-title":"Prevention of transfusion-transmitted infections","volume":"133","author":"Busch","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2023.150769_bib0002","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tmrv.2020.02.001","article-title":"Screening blood donors for HIV, HCV, and HBV at the American Red Cross: 10-year trends in prevalence, incidence, and residual risk, 2007 to 2016","volume":"34","author":"Dodd","year":"2020","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2023.150769_bib0003","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/trf.16250","article-title":"HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12-month deferral policy for men who have sex with men","volume":"61","author":"Steele","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0004","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7326\/0003-4819-157-1-201206190-00429","article-title":"Red blood cell transfusion: a clinical practice guideline from the AABB*","volume":"157","author":"Carson","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tmrv.2023.150769_bib0005","doi-asserted-by":"crossref","DOI":"10.7326\/M15-1329","article-title":"Emerging infections and blood safety in the 21st century","author":"Bloch","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tmrv.2023.150769_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tmrv.2016.08.001","article-title":"Zika virus and the blood supply: what do we know?","volume":"31","author":"Jimenez","year":"2017","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2023.150769_bib0007","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/trf.15831","article-title":"Is SARS-CoV-2 transfusion transmitted?","volume":"60","author":"Katz","year":"2020","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0008","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tmrv.2022.09.004","article-title":"Monkeypox and transfusion safety","volume":"37","author":"Dodd","year":"2023","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2023.150769_bib0009","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1537-2995.2012.03742.x","article-title":"Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st century","volume":"53","author":"Glynn","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/vox.12620","article-title":"Pathogen reduction and blood transfusion safety in Africa: strengths, limitations and challenges of implementation in low-resource settings","volume":"113","author":"Ware","year":"2018","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2023.150769_bib0011","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/S0140-6736(16)00581-X","article-title":"Effect of Plasmodium inactivation in whole blood on the incidence of blood transfusion-transmitted malaria in endemic regions: the African Investigation of the Mirasol System (AIMS) randomised controlled trial","volume":"387","author":"Allain","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2023.150769_bib0012","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1056\/NEJMp1500154","article-title":"The safety of the blood supply: time to raise the bar","volume":"372","author":"Snyder","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2023.150769_bib0013","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13063-022-06137-8","article-title":"The Mirasol Evaluation of Reduction in Infections Trial (MERIT): study protocol for a randomized controlled clinical trial","volume":"23","author":"Kasirye","year":"2022","journal-title":"Trials"},{"key":"10.1016\/j.tmrv.2023.150769_bib0014","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/trf.17296","article-title":"Proceedings of the 2022 NHLBI and OASH state of the science in transfusion medicine symposium","volume":"63","author":"Custer","year":"2023","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0015","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(78)90131-9","article-title":"Transmissible agent in non-A, non-B hepatitis","volume":"1","author":"Alter","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2023.150769_bib0016","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0140-6736(78)90132-0","article-title":"Transmission of non-A, non-B hepatitis from man to chimpanzee","volume":"1","author":"Tabor","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2023.150769_bib0017","first-page":"359","article-title":"Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome","volume":"244","author":"Choo","year":"1989","journal-title":"Science (1979)"},{"key":"10.1016\/j.tmrv.2023.150769_bib0018","unstructured":"NIH. NIH intramural researcher Dr. Harvey Alter wins 2020 Nobel Prize in physiology or medicine. 2020. https:\/\/www.nih.gov\/news-events\/news-releases\/nih-intramural-researcher-dr-harvey-alter-wins-2020-nobel-prize-physiology-or-medicine Accessed June 3, 2023."},{"key":"10.1016\/j.tmrv.2023.150769_bib0019","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa1402454","article-title":"Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection","volume":"370","author":"Afdhal","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2023.150769_bib0020","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1097\/00002030-200309050-00005","article-title":"Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection","volume":"17","author":"Fiebig","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.tmrv.2023.150769_bib0021","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1537-2995.2004.04215.x","article-title":"A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors","volume":"45","author":"Busch","year":"2005","journal-title":"Transfusion"},{"issue":"suppl 2","key":"10.1016\/j.tmrv.2023.150769_bib0022","doi-asserted-by":"crossref","first-page":"S270","DOI":"10.1086\/655651","article-title":"The detection of acute HIV infection","volume":"202","author":"Cohen","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmrv.2023.150769_bib0023","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1073\/pnas.0802203105","article-title":"Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection","volume":"105","author":"Keele","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmrv.2023.150769_bib0024","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jtbi.2009.07.038","article-title":"Modeling sequence evolution in acute HIV-1 infection","volume":"261","author":"Lee","year":"2009","journal-title":"J Theor Biol"},{"issue":"suppl 1","key":"10.1016\/j.tmrv.2023.150769_bib0025","first-page":"317","article-title":"Testing for HIV: the first three decades","volume":"10","author":"Busch","year":"2014","journal-title":"ISBT Sci Ser"},{"key":"10.1016\/j.tmrv.2023.150769_bib0026","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1128\/JVI.01844-08","article-title":"Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections","volume":"83","author":"Stacey","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.tmrv.2023.150769_bib0027","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1537-2995.2005.04390.x","article-title":"Dynamics of viremia in early hepatitis C virus infection","volume":"45","author":"Glynn","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0028","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1046\/j.1537-2995.2003.00424.x","article-title":"Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection","volume":"43","author":"Biswas","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0029","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/trf.13819","article-title":"Detection of different categories of hepatitis B virus (HBV) infection in a multi-regional study comparing the clinical sensitivity of hepatitis B surface antigen and HBV-DNA testing","volume":"57","author":"Lelie","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0030","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1086\/591467","article-title":"Virus and antibody dynamics in acute West Nile Virus infection","volume":"198","author":"Busch","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmrv.2023.150769_bib0031","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3201\/eid2207.160116","article-title":"High incidence of Chikungunya virus and frequency of viremic blood donations during epidemic, Puerto Rico, USA, 2014","volume":"22","author":"Simmons","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.tmrv.2023.150769_bib0032","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S1473-3099(19)30706-6","article-title":"Evolving viral and serological stages of Zika virus RNA-positive blood donors and estimation of incidence of infection during the 2016 Puerto Rican Zika epidemic: an observational cohort study","volume":"20","author":"Williamson","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tmrv.2023.150769_bib0033","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1111\/j.1537-2995.2006.00957.x","article-title":"Transfusion-transmitted viral infections: building bridges to transfusion medicine to reduce risks and understand epidemiology and pathogenesis","volume":"46","author":"Busch","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0034","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/QAD.0000000000002190","article-title":"A generalizable method for estimating duration of HIV infections using clinical testing history and HIV test results","volume":"33","author":"Pilcher","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.tmrv.2023.150769_bib0035","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1742-4690-10-56","article-title":"A novel acute HIV infection staging system based on 4th generation immunoassay","volume":"10","author":"Ananworanich","year":"2013","journal-title":"Retrovirology"},{"key":"10.1016\/j.tmrv.2023.150769_bib0036","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1111\/j.1537-2995.2009.02322.x","article-title":"Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion","volume":"49","author":"Kleinman","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0037","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/jama.280.1.42","article-title":"New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes","volume":"280","author":"Janssen","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.tmrv.2023.150769_bib0038","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1097\/QAD.0b013e32833f1142","article-title":"Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation","volume":"24","author":"Busch","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.tmrv.2023.150769_bib0039","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1182\/blood.2020007003","article-title":"HIV incidence in US first-time blood donors and transfusion risk with a 12-month deferral for men who have sex with men","volume":"136","author":"Grebe","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2023.150769_bib0040","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/cid\/ciw369","article-title":"Editorial commentary: timing is everything: shortcomings of current HIV diagnostics in the early treatment era","volume":"63","author":"Keating","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmrv.2023.150769_bib0041","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/infdis\/jiz145","article-title":"Discovery of false elite controllers: HIV antibody-positive RNA-negative blood donors found to Be on antiretroviral therapy","volume":"220","author":"Sykes","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmrv.2023.150769_bib0042","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1182\/blood.2020006890","article-title":"HIV antiretroviral therapy and prevention use in US blood donors: a new blood safety concern","volume":"136","author":"Custer","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2023.150769_bib0043","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1182\/blood.2020008122","article-title":"ART and science of keeping HIV out of the blood supply","volume":"136","author":"Kaufman","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2023.150769_bib0044","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3201\/eid1205.051287","article-title":"West Nile virus infections projected from blood donor screening data, United States, 2003","volume":"12","author":"Busch","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.tmrv.2023.150769_bib0045","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1056\/NEJMoa1600897","article-title":"Screening for Babesia microti in the U.S. blood supply","volume":"375","author":"Moritz","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2023.150769_bib0046","unstructured":"FDA. BLA approval letter, March 6, 2018: Babesia microti AFIA\/Babesia microti In: OBRR\/CBER, editor: Silver Spring, MD: Food and Drug Administration; 2018. https:\/\/www.fda.gov\/media\/111850\/download. Accessed August, 2023."},{"key":"10.1016\/j.tmrv.2023.150769_bib0047","article-title":"Recommendations for reducing the risk of transfusion-transmitted babesiosis. In: F.a.D.A.C.f.B.E.a.R. U.S. Department of Health and Human Services, editor. Silver Spring","year":"2019","journal-title":"MD: Food and Drug Administration"},{"key":"10.1016\/j.tmrv.2023.150769_bib0048","unstructured":"FDA. BLA approval letter, January 24, 2019 In: CBER, editor Silver Spring, MD: Food and Drug Administration; 2019. https:\/\/www.fda.gov\/media\/119872\/download. Accessed August, 2023."},{"key":"10.1016\/j.tmrv.2023.150769_bib0049","unstructured":"FDA. cobas Babesia. 2019. https:\/\/www.fda.gov\/vaccines-blood-biologics\/cobas-babesia Accessed October 23, 2021."},{"key":"10.1016\/j.tmrv.2023.150769_bib0050","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10091176","article-title":"Preventing transfusion-transmitted babesiosis","volume":"10","author":"Bloch","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.tmrv.2023.150769_bib0051","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/trf.16718","article-title":"Babesia blood testing: the first-year experience","volume":"62","author":"Tonnetti","year":"2022","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0052","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1111\/trf.15425","article-title":"Characteristics of transfusion-transmitted Babesia microti, American Red Cross 2010\u20132017","volume":"59","author":"Tonnetti","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0053","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/trf.15630","article-title":"Transcription-mediated amplification blood donation screening for Babesia","volume":"60","author":"Tonnetti","year":"2020","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0054","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1111\/trf.16617","article-title":"Detection of Babesia RNA and DNA in whole blood samples from US blood donations","volume":"61","author":"Stanley","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0055","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1001\/jama.2021.15161","article-title":"Estimated US infection- and vaccine-induced SARS-CoV-2 seroprevalence based on blood donations, July 2020-May 2021","volume":"326","author":"Jones","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.tmrv.2023.150769_bib0056","doi-asserted-by":"crossref","first-page":"601","DOI":"10.15585\/mmwr.mm7222a3","article-title":"Estimates of SARS-CoV-2 seroprevalence and incidence of primary SARS-CoV-2 infections among blood donors, by COVID-19 vaccination status - United States, April 2021-September 2022","volume":"72","author":"Jones","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.tmrv.2023.150769_bib0057","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJM198911303212202","article-title":"Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis","volume":"321","author":"Alter","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2023.150769_bib0058","first-page":"365","article-title":"Pneumocystis carinii pneumonia among persons with hemophilia A","volume":"31","year":"1982","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.tmrv.2023.150769_bib0059","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(83)92082-2","article-title":"Acquired immunodeficiency in an infant: possible transmission by means of blood products","volume":"1","author":"Ammann","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2023.150769_bib0060","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1056\/NEJMsb1704752","article-title":"Revisiting blood safety practices given emerging data about Zika virus","volume":"378","author":"Bloch","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2023.150769_bib0061","doi-asserted-by":"crossref","first-page":"556","DOI":"10.7326\/0003-4819-155-8-201110180-00363","article-title":"Transfusion-associated babesiosis: shouldn't we be ticked off?","volume":"155","author":"Leiby","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tmrv.2023.150769_bib0062","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/trf.15118","article-title":"Impact of one-time testing for Trypanosoma cruzi antibodies among blood donors in the United States","volume":"59","author":"Dodd","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0063","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1111\/j.1537-2995.2012.03569.x","article-title":"Epidemiologic and laboratory findings from 3 years of testing United States blood donors for Trypanosoma cruzi","volume":"52","author":"Custer","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0064","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJMoa030969","article-title":"Transmission of West Nile virus through blood transfusion in the United States in 2002","volume":"349","author":"Pealer","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2023.150769_bib0065","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1532\/IJH97.04123","article-title":"Current safety of the blood supply in the United States","volume":"80","author":"Dodd","year":"2004","journal-title":"Int J Hematol"},{"key":"10.1016\/j.tmrv.2023.150769_bib0066","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/j.1537-2995.2009.02127.x","article-title":"West Nile virus testing experience in 2007: evaluation of different criteria for triggering individual-donation nucleic acid testing","volume":"49","author":"Kleinman","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0067","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tmrv.2015.03.001","article-title":"Keeping blood transfusion safe from West Nile Virus: American Red Cross experience, 2003 to 2012","volume":"29","author":"Dodd","year":"2015","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2023.150769_bib0068","doi-asserted-by":"crossref","first-page":"375","DOI":"10.15585\/mmwr.mm6514e1","article-title":"Survey of blood collection centers and implementation of guidance for prevention of transfusion-transmitted Zika virus infection: Puerto Rico, 2016","volume":"65","author":"Vasquez","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.tmrv.2023.150769_bib0069","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJMoa1714977","article-title":"Investigational testing for Zika virus among U.S. blood donors","volume":"378","author":"Saa","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2023.150769_bib0070","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/trf.14029","article-title":"First Zika-positive donations in the continental United States","volume":"57","author":"Galel","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0071","unstructured":"A. Russel. Should the United States keep screening all blood donations for Zika? 2021. https:\/\/engineering.stanford.edu\/magazine\/article\/should-united-states-keep-screening-all-blood-donations-zika Accessed May 3, 2023."},{"key":"10.1016\/j.tmrv.2023.150769_bib0072","doi-asserted-by":"crossref","first-page":"164","DOI":"10.7326\/M18-2238","article-title":"Screening the blood supply for Zika virus in the 50 U.S. States and Puerto Rico: a cost-effectiveness analysis","volume":"170","author":"Russell","year":"2019","journal-title":"Ann Intern Med"},{"issue":"suppl 2","key":"10.1016\/j.tmrv.2023.150769_bib0073","article-title":"Emerging infectious disease agents and their potential threat to transfusion safety","volume":"49","author":"Stramer","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0074","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/S0140-6736(11)60899-4","article-title":"XMRV and CFS: the sad end of a story","volume":"379","author":"van Kuppeveld","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2023.150769_bib0075","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1537-2995.2008.01646.x","article-title":"Estimated risk of Chikungunya viremic blood donation during an epidemic on Reunion Island in the Indian Ocean, 2005 to 2007","volume":"48","author":"Brouard","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0076","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3390\/pathogens10091176","article-title":"Preventing transfusion-transmitted babesiosis","volume":"10","author":"Bloch","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.tmrv.2023.150769_bib0077","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/trf.15762","article-title":"Bacterial contamination rate of platelet components by primary culture: a systematic review and meta-analysis","volume":"60","author":"White","year":"2020","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0078","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1111\/trf.14306","article-title":"Residual risk of bacterial contamination: what are the options?","volume":"57","author":"Bloch","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0079","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/vox.12708","article-title":"Risk-based decision making in transfusion medicine","volume":"113","author":"Bennett","year":"2018","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2023.150769_bib0080","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/voxs.12500","article-title":"A risk-based decision-making framework for blood safety: what's the case for Zika?","volume":"15","author":"Bloch","year":"2020","journal-title":"ISBT Sci Ser"},{"key":"10.1016\/j.tmrv.2023.150769_bib0081","unstructured":"ABO. Risk-based decision-making: elements and structure of the framework. Alliance of Blood Operators. 2014. https:\/\/www.allianceofbloodoperators.org\/abo-resources\/risk-based-decision-making\/rbdm-framework.aspx Accessed March 7, 2019."},{"key":"10.1016\/j.tmrv.2023.150769_bib0082","unstructured":"S. Bagnato, B. Custer, S. Ghibu, M. Giroux, M. Granato, M. Janssen, et\u00a0al. Risk-based decision-making framework for blood safety. Alliance of Blood Operators; 2014. https:\/\/www.allianceofbloodoperators.org\/media\/101766\/ABO-Risk-based-decision-making-framework-for-blood-safety-for-consultation.pdf. Accessed October 19, 2023."},{"key":"10.1016\/j.tmrv.2023.150769_bib0083","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1111\/trf.14247","article-title":"Mitigation of the threat posed to transfusion by donors traveling to Zika-affected areas: a Canadian risk-based approach","volume":"57","author":"Germain","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0084","unstructured":"FDA. Use of serological tests to reduce the risk of transmission of Trypanosoma cruzi infection in blood and blood components: guidance for industry. In: CBER, editor. Silver Spring, MD: Food and Drug Administration; 2017."},{"key":"10.1016\/j.tmrv.2023.150769_bib0085","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/j.1537-2995.2010.02851.x","article-title":"Transfusion-associated infections: 50 years of relentless challenges and remarkable progress","volume":"50","author":"Perkins","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0086","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1056\/NEJMoa040085","article-title":"Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing","volume":"351","author":"Stramer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2023.150769_bib0087","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJMoa1007644","article-title":"Nucleic acid testing to detect HBV infection in blood donors","volume":"364","author":"Stramer","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2023.150769_bib0088","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1212\/WNL.48.2.315","article-title":"HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigators","volume":"48","author":"Murphy","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2023.150769_bib0089","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3201\/eid1001.020714","article-title":"Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection","volume":"10","author":"Murphy","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.tmrv.2023.150769_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005254","article-title":"Epidemiology of Chikungunya Virus outbreaks in Guadeloupe and Martinique, 2014: an observational study in volunteer blood donors","volume":"11","author":"Gallian","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.tmrv.2023.150769_bib0091","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/infdis\/jiac173","article-title":"Surveillance for Zika, Chikungunya, and Dengue Virus incidence and RNAemia in blood donors at 4 Brazilian blood centers during 2016-2019","volume":"227","author":"Custer","year":"2023","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmrv.2023.150769_bib0092","first-page":"267","article-title":"Prevalence of Chikungunya, Dengue and Zika viruses in blood donors: a systematic literature review and meta-analysis","volume":"20","author":"Gim\u00e9nez-Richarte","year":"2022","journal-title":"Blood Transfus"},{"key":"10.1016\/j.tmrv.2023.150769_bib0093","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3201\/eid2305.161873","article-title":"Use of blood donor screening data to estimate Zika virus incidence, Puerto Rico, April-August 2016","volume":"23","author":"Chevalier","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.tmrv.2023.150769_bib0094","doi-asserted-by":"crossref","first-page":"1001.e1","DOI":"10.1016\/j.cmi.2017.07.006","article-title":"Detection of Zika virus RNA in semen of asymptomatic blood donors","volume":"23","author":"Musso","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.tmrv.2023.150769_bib0095","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJMoa044333","article-title":"West Nile virus among blood donors in the United States, 2003 and 2004","volume":"353","author":"Stramer","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2023.150769_bib0096","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1086\/656602","article-title":"West Nile fever characteristics among viremic persons identified through blood donor screening","volume":"202","author":"Zou","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmrv.2023.150769_bib0097","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1161\/CIRCULATIONAHA.112.123612","article-title":"Ten-year incidence of Chagas cardiomyopathy among asymptomatic trypanosoma cruzi-seropositive former blood donors","volume":"127","author":"Sabino","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.tmrv.2023.150769_bib0098","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1086\/516534","article-title":"Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' Disease, in US blood donors","volume":"176","author":"Leiby","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmrv.2023.150769_bib0099","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1111\/j.1537-2995.2012.03581.x","article-title":"The United States Trypanosoma cruzi Infection Study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors","volume":"52","author":"Cantey","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0100","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1111\/j.1537-2995.2009.02430.x","article-title":"Seroprevalence of Babesia microti in blood donors from Babesia-endemic areas of the northeastern United States: 2000 through 2007","volume":"49","author":"Johnson","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0101","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/trf.17244","article-title":"Transfusion-transmitted babesiosis in a patient with sickle cell disease undergoing chronic red cell exchange","volume":"63","author":"Costa","year":"2023","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0102","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1111\/j.1537-2995.2005.00609.x","article-title":"Demonstrable parasitemia among Connecticut blood donors with antibodies to Babesia microti","volume":"45","author":"Leiby","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0103","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1111\/trf.12693","article-title":"Investigational screening for Babesia microti in a large repository of blood donor samples from nonendemic and endemic areas of the United States","volume":"54","author":"Moritz","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0104","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/trf.12763","article-title":"Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay","volume":"54","author":"Levin","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0105","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/trf.13618","article-title":"Serologic screening of United States blood donors for Babesia microti using an investigational enzyme immunoassay","volume":"56","author":"Levin","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0106","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1159\/000528793","article-title":"Molecular screening of blood donors for Babesia in Tyrol, Austria","volume":"50","author":"Bloch","year":"2023","journal-title":"Transfus Med Hemotherapy"},{"key":"10.1016\/j.tmrv.2023.150769_bib0107","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4269\/ajtmh.18-0012","article-title":"Babesia microti and malaria infection in Africa: a pilot serosurvey in Kilosa District, Tanzania","volume":"99","author":"Bloch","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmrv.2023.150769_bib0108","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1111\/trf.15415","article-title":"Sociodemographic and behavioral characteristics associated with blood donation in the United States: a population-based study","volume":"59","author":"Patel","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0109","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/trf.14949","article-title":"Blood transfusion safety in sub-Saharan Africa: a literature review of changes and challenges in the 21st century","volume":"59","author":"Weimer","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150769_bib0110","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJMsb1706496","article-title":"Crisis in the sustainability of the U.S. Blood system","volume":"377","author":"Klein","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796323000597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796323000597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:21:42Z","timestamp":1760138502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796323000597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":110,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0887796323000597"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2023.150769","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leveraging Donor Populations to Study the Epidemiology and Pathogenesis of Transfusion-Transmitted and Emerging Infectious Diseases","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2023.150769","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"150769"}}